scispace - formally typeset
M

Mohammed J. R. Ghori

Researcher at Wellcome Trust Sanger Institute

Publications -  21
Citations -  14727

Mohammed J. R. Ghori is an academic researcher from Wellcome Trust Sanger Institute. The author has contributed to research in topics: Biology & Genome. The author has an hindex of 11, co-authored 13 publications receiving 13359 citations.

Papers
More filters
Journal ArticleDOI

Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

Paul Burton, +195 more
- 07 Jun 2007 - 
TL;DR: This study has demonstrated that careful use of a shared control group represents a safe and effective approach to GWA analyses of multiple disease phenotypes; generated a genome-wide genotype database for future studies of common diseases in the British population; and shown that, provided individuals with non-European ancestry are excluded, the extent of population stratification in theBritish population is generally modest.
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

Paul Burton, +224 more
- 01 Nov 2007 - 
TL;DR: In this paper, the authors report initial association and independent replication in a North American sample of two new loci related to ankylosing spondylitis, ARTS1 and IL23R, and confirm the previously reported association of AITD with TSHR and FCRL3.
Journal ArticleDOI

DNA sequence and analysis of human chromosome 9

Andrew J. Mungall, +170 more
- 23 Oct 2003 - 
TL;DR: Analysis of the sequence reveals many intra- and interchromosomal duplications, including segmental duplications adjacent to both the centromere and the large heterochromatic block, and detects recently duplicated genes that exhibit different rates of sequence divergence, presumably reflecting natural selection.
Journal ArticleDOI

The largest prospective warfarin-treated cohort supports genetic forecasting.

TL;DR: It is strongly supported that initiation of warfarin guided by pharmacogenetics would improve clinical outcome and predicted individuals predisposed to unstable anticoagulation.